Related Experiment Videos
[Is hyperthyroidism often present in patients with thyroid differentiated carcinoma?]
Paweł Bolko1, Katarzyna Łacka, Ewa Manuszewska
1Katedra i Klinika Endoktynologii i Przemiany Materii AM w Poznaniu.
Polskie Archiwum Medycyny Wewnetrznej
|October 10, 2002
Summary
This study found that 9.1% of differentiated thyroid cancer patients had pre-existing hyperthyroidism, often linked to goiter or Graves disease. This highlights the need for careful evaluation of hyperthyroid patients for coexisting thyroid cancer.
Area of Science:
- Endocrinology
- Oncology
- Pathology
Background:
- The coexistence of thyroid cancer and hyperthyroidism is frequently observed.
- Inadequate diagnostic methods and surgical qualification can lead to underdiagnosis of hyperthyroidism in patients with nodular goiter or Graves disease, especially when coexisting with nodules.
Purpose of the Study:
- To estimate the occurrence of hyperthyroidism in patients diagnosed with differentiated thyroid cancer.
Main Methods:
- Retrospective analysis of 217 patients with differentiated thyroid cancer.
- Review of pre-existing diagnoses of hyperthyroidism, including hyperfunctional nodular goiter and Graves disease (confirmed by anti-TSH receptor antibodies).
- Evaluation of pre- and post-thyroidectomy findings, including ultrasonography and histopathological examination.
Main Results:
- Twenty patients (9.1%) with differentiated thyroid cancer had a prior diagnosis of hyperthyroidism.
- Of these, 17 had hyperfunctional nodular goiter and 3 had Graves disease.
- Post-thyroidectomy, 16 papillary and 4 follicular thyroid cancers were diagnosed in the hyperthyroid group.
Conclusions:
- The observed frequency of 9.1% for the coexistence of hyperthyroidism and differentiated thyroid cancer aligns with existing literature.
- Precise analysis of hyperthyroid patients and careful surgical qualification are crucial for identifying potential coexisting thyroid malignancies.